| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 25.06. | Real-Time Trials Are Here - Now We Need Real-Time Trust | ||
| 25.06. | Where Patient Education Breaks Down in Breast Cancer Care | ||
| 25.06. | How Are Payers and Providers Thinking of AI and Cybersecurity? | ||
| 25.06. | New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in Breast Cancer | ||
| 25.06. | New Partnership Aims to Lower Out-of-Pocket Costs, Even Eliminate Them In Some Cases | ||
| 25.06. | Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn't | ||
| 24.06. | Keeping Up With Clinicians | ||
| 24.06. | Women's Health Is Not a Wearable Feature - It's an Operating System Problem | ||
| 24.06. | From Trial-and-Error to Targeted Success: How Computational Disease Models Can Help Patients and Pharma Companies | ||
| 24.06. | Care Without Walls: Scaling Alternatives to Skilled Nursing Facilities | ||
| 24.06. | The Payer AI Readiness Gap: Why Better Data Will Define the Next Era of Health Plan Performance | ||
| 24.06. | The Things to Think About Before Taking Your Biotech Company Public | ||
| 24.06. | Cadence Rakes In $100M to Automate Chronic Care at Scale | ||
| 24.06. | Startup Raises $7M for Virtual-First Pediatric Therapy Model | ||
| 23.06. | Why Healthcare AI is Missing the Point | ||
| 23.06. | Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers | ||
| 23.06. | Washington's Medical Debt Push Risks Missing the Bigger Healthcare Crisis | ||
| 23.06. | Why So Few Appeals Happen and What That Reveals About Health Plans | ||
| 23.06. | AbbVie's $11B Apogee Acquisition Brings an Eczema Drug With an Edge | ||
| 23.06. | Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts | ||
| 23.06. | Abarca Health and LucyRx to Combine to Scale Independent PBM Model | ||
| 22.06. | Alternative Health Plan Designs Are Reshaping Employer Benefits | ||
| 22.06. | Passive Immunization: The Expanding Role of Monoclonal Antibodies in Preventive Medicine | ||
| 22.06. | Preparing Healthcare Networks For The Vulnerability Flood | ||
| 22.06. | Inflammation Startup Bionyra Launches With $165M and Ex-Sanofi Exec at the Helm |